描述
Ferrostatin-1 铁死亡抑制剂
产品标签
Ferrostatin-1(Fer-1);Erastin;Ferroptosis 铁死亡;Ferroptosis inhibitor;FeRhoNox-1 亚铁离子荧光探针;C11 BODIPY 581/591 脂质过氧化荧光探针;CAS:347174-05-4;
产品信息:
产品名称 |
产品编号 | CAS NO. | 规格 | 价格(元) |
Ferrostatin-1 铁死亡抑制剂 |
MZ5271-5MG | 347174-05-4 | 5mg |
680 |
Ferrostatin-1 铁死亡抑制剂 | MZ5271-25MG | 347174-05-4 | 25mg |
2580 |
Ferrostatin-1 铁死亡抑制剂 | MZ5271-100MG | 347174-05-4 | 100mg |
8860 |
产品描述
铁死亡(Ferroptosis)是一种铁依赖形式的非凋亡性细胞死亡。Ferrostatin-1(Fer-1)是一种有效的、选择性的铁死亡抑制剂。HT-1080细胞中,Fer-1(0.5μM)抑制铁死亡激活剂Erastin(Cat#:MZ5272,EC50=60nM)和RSL3诱导的细胞死亡,但对过氧化氢、鱼藤酮,或星孢菌素诱导的细胞死亡没有效果。Fer-1抑制Erastin诱导的活性氧生成和脂质过氧化。在基于细胞水平的亨廷顿病、脑室周围白质软化症(PVL)和近端肾小管损伤模型中,Fer-1以剂量依赖性的方式提高细胞存活率。大鼠海马器官型脑片培养模型中,Fer-1(2μM)抑制L-谷氨酸盐诱导的细胞死亡。Fer-1还能通过捕获过氧自由基的方式阻抑脂质自氧化。
产品特性
1) CAS NO:347174-05-4
2) 化学名:Ethyl 3-amino-4-(cyclohexylamino)benzoate; 3-amino-4-(cyclohexylamino)-benzoic acid,ethyl ester;
3) 分子式:C15H22N2O2
4) 分子量:262.35
5) 外观:淡紫色至棕褐色固体
6) 纯度:≥99%(HPLC)
7) 溶解性:溶于DMSO(≥9.5mg/ml)、乙醇(≥50mg/ml,需要超声助溶)、不溶于水
8) 化学结构式:
保存与运输方法
保存:-20℃干燥保存,至少2年有效;
运输:冰袋运输。
注意事项
1) 关于化合物溶解性:产品特性内的“≥”表明溶于标示浓度,但饱和溶解度未知。不同批次化合物的溶解度会有差异。
2) 为了让化合物更好的溶解,可通过37℃加热或(和)超声波水浴中震动片刻来处理。若实验所需浓度过大甚至达产品溶解极限,请添加助溶剂助溶或自行调整浓度。
3) 本品仅用作科研用途,不可用于临床或诊疗用途。
4) 为了您的安全和健康,请穿实验服并戴一次性手套操作。
储存液制备
质量
溶剂体积 浓度 |
1mg | 5mg | 10mg |
1mM | 3.81 mL | 19.06 mL | 38.12 mL |
5mM | 0.76 mL | 3.81 mL | 7.62 mL |
10mM | 0.38 mL | 1.91 mL | 3.81 mL |
50mM | 0.08 mL | 0.38 mL | 0.76 mL |
【温馨提示】:请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。储备液置于-80°C保存,约6个月有效;-20°C保存,约1个月有效。
使用方法【源自文献,仅作参考】
文献1,Chu, Jun et al. “Ferrostatin-1 protects HT-22 cells from oxidative toxicity.” Neural regeneration research vol. 15,3 (2020): 528-536. doi:10.4103/1673-5374.266060 PMID: 31571665
体外研究(细胞水平): 细胞类型(Cell Type):HT-22 cells 实验方法(Assay):HT-22 cells were seeded in 6-well culture plate (2 × 105 cells/well). Glutamate (1.25, 2.5, 5, 10, 20 mM) was applied to HT-22 cells for 12, 24, 36, and 48 hours. HT-22 cells were cultured with different concentrations of ferrostatin-1 (3, 6 and 12μM) for 16 hours prior to exposure to 5 mM glutamate. After 24 hours, the subsequent analyses were conducted. 结果说明(Result):Ferrostatin-1 dose-dependently reduced cell death, with a maximum effect at a dose of 12 μM, but had no significant effect on the survival of HT-22 cells deprived of glutamate. |
文献2,Liu, P., Feng, Y., Li, H. et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell Mol Biol Lett 25, 10 (2020). PMID: 32161620
体内研究(动物模型): 动物模型(Animal Model):Male C57BL/6 mice 实验方法(Assay):The LPS-induced ALI model was induced by instilling intratracheally 50 μl of LPS solution (0.2 g/L), then Fer-1 (0.8 mg/kg) was administered after LPS challenge via tail vein injection. The Fer-1 was dissolved in DMSO first, and diluted with 0.9% NaCl. The final concentration of Fer-1 and DMSO was 0.2 mg/ml and 0.1% respectively. After the treatments for 16 h, the mice in each group were euthanized and bronchoalveolar lavage (BAL) fluid was collected via lung lavage. |
相关产品
货号 | 名称 | 规格 |
MZ5271-5MG | Ferrostatin-1 铁死亡抑制剂 | 5mg |
MZ5272-5MG | Erastin 铁死亡激活剂 | 5mg |
MX4558-50UG | FeRhoNox-1 (Fe2+ indicator) 亚铁离子荧光探针 | 50μg |
MX4559-24UG | FerroOrange (Fe2+ indicator) 亚铁离子荧光探针 | 24μg |
MX5211-1MG | C11 BODIPY 581/591 脂质过氧化荧光探针 | 1mg |